Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin

Uncertainty regarding an optimal antiplatelet regimen still exists in patients with breakthrough acute ischemic stroke (AIS) while on aspirin. This study provides an analysis of a prospective multicenter registry between April 2008 and April 2014. Eligible patients were on aspirin at the time of AIS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kim, Joon-Tae, Kim, Beom Joon, Park, Jong-Moo, Lee, Soo Joo, Cha, Jae-Kwan, Park, Tai Hwan, Lee, Kyung Bok, Lee, Jun, Hong, Keun-Sik, Lee, Byung-Chul, Kim, Dong-Eog, Choi, Jay Chol, Kwon, Jee-Hyun, Shin, Dong-Ick, Sohn, Sung Il, Lee, Ji Sung, Lee, Juneyoung, Bae, Hee-Joon
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://ncbi.nlm.nih.gov/pubmed/33028887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73836-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars